Cargando…
Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies
Due to the severity of COVID-19 disease, the U.S. Centers for Disease Control and Prevention and World Health Organization recommend that manipulation of active viral cultures of SARS-CoV-2 and respiratory secretions from COVID-19 patients be performed in biosafety level (BSL)3 laboratories. Therefo...
Autores principales: | Eddins, Devon J., Bassit, Leda C., Chandler, Joshua D., Haddad, Natalie S., Musall, Kathryn L., Yang, Junkai, Kosters, Astrid, Dobosh, Brian S., Hernández, Mindy R., Ramonell, Richard P., Tirouvanziam, Rabindra M., Lee, F. Eun-Hyung, Zandi, Keivan, Schinazi, Raymond F., Ghosn, Eliver E. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164212/ https://www.ncbi.nlm.nih.gov/pubmed/35173021 http://dx.doi.org/10.4049/immunohorizons.2200005 |
Ejemplares similares
-
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
por: Dobosh, Brian, et al.
Publicado: (2022) -
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load
por: Eddins, Devon J., et al.
Publicado: (2022) -
Elimination of Aicardi–Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication
por: Oo, Adrian, et al.
Publicado: (2022) -
Comprehensive multi-omics single-cell data integration reveals greater heterogeneity in the human immune system
por: Xu, Congmin, et al.
Publicado: (2022) -
Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)